Grifols Egypt for Plasma Derivatives (GEPD)
Developing plasma medicines market
- B2B
- B2G
About Grifols Egypt for Plasma Derivatives (GEPD)
A pioneering joint-venture focused on developing the plasma medicines market in Egypt, aiming for self-sufficiency in critical therapies through widespread plasma donation centers and manufacturing facilities
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 251–1,000 employees
- Headquarters
- Cairo, Cairo Governorate, Egypt
- Revenue
- $16.6M – $131MTamtam estimate
- Website
- grifolsegyptplasma.com
Grifols Egypt for Plasma Derivatives (GEPD) at a glance
Grifols Egypt for Plasma Derivatives (GEPD) is a B2B/B2G company in the Pharmaceutical Manufacturing industry, headquartered in Cairo, Cairo Governorate, Egypt.
Grifols Egypt for Plasma Derivatives (GEPD) has 251–1,000 employees.
Grifols Egypt for Plasma Derivatives (GEPD)'s revenue is $16.6M – $131M (Tamtam estimate).
Selling to companies like Grifols Egypt for Plasma Derivatives (GEPD)?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies